Korea Investment Corp’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-26,304	Closed	-$4.86M	–	724
2024 Q4	$4.86M	Sell	26,304 -42,200	-62%	-$8.13M	0.01%	624
2024 Q3	$13.5M	Buy	68,504 +22,347	+48%	+$4.64M	0.03%	425
2024 Q2	$9.54M	Buy	46,157 +5,221	+13%	+$1.18M	0.02%	467
2024 Q1	$11.1M	Buy	40,936 +15,659	+62%	+$3.74M	0.03%	441
2023 Q4	$5.98M	Buy	25,277 +11,228	+80%	+$2.21M	0.02%	551
2023 Q3	$2.75M	Sell	14,049 -4,154	-23%	-$853K	0.01%	614
2023 Q2	$3.83M	Buy	18,203 +1,249	+7%	+$249K	0.01%	567
2023 Q1	$3.42M	Sell	16,954 -2,261	-12%	-$512K	0.01%	606
2022 Q4	$4.19M	Sell	19,215 -4,315	-18%	-$942K	0.01%	581
2022 Q3	$4.63M	Sell	23,530 -9,687	-29%	-$2.09M	0.01%	568
2022 Q2	$7.11M	Buy	33,217 +14,917	+82%	+$3.64M	0.02%	489
2022 Q1	$5.2M	Buy	18,300 +5,600	+44%	+$1.73M	0.01%	569
2021 Q4	$4.79M	Buy	12,700 +900	+8%	+$350K	0.01%	527
2021 Q3	$4.87M	Buy	11,800 +1,000	+9%	+$415K	0.01%	515
2021 Q2	$4M	Buy	+10,800	New	+$3.61M	0.01%	577